Overview: Kexing Biopharm Co., Ltd. focuses on the research, development, production, and sale of recombinant protein drugs and microbial preparations both in China and internationally, with a market ...

For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic ...

A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered—which ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

These proteins also serve as useful tools in determining drug candidates’ binding affinity ... whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

The report delivers a comprehensive analysis of global biologics sales. Covering cancer antibodies, non-TNF inflammatory mAbs, biosimilars, gene therapy, RNA-based drugs, and more, the report provides ...

Micreos Pharmaceuticals AG (”Micreos”), a preclinical-stage biopharmaceutical company, specializing in developing Engineered Endolysin therapies to target harmful pathogens that cause disease ...

Antibody-Drug Conjugates (ADCs): These ... biomarkers having a high precision. Recombinant antibodies are used in the study of cellular pathways, protein-protein interactions, and molecular ...